EGFR and neoplasm: Finally, to test the therapeutic potential of PEGylated SSNs as a tool for functional siRNA delivery in vivo, both SSNs and PEG-SSNs were electrostatically associated with EGFR siRNA and tested in 4T1 tumour-bearing mice for evaluating anticancer effects in a pre-clinical setting.